\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBrussels
We are pleased to invite you to the upcoming CERIS event on "Securing major public events" on 12 December in Brussels.
This event presented by DG HOME, aims to bring together practitioners, local authorities, policymakers and researches to discuss trends, risks, further research and lessons learned from the multitude of major public events taking place over the course of the year 2024. This event will look at security research needs and new threats, advanced technologies, crisis preparedness, and ethical and legal considerations in this field.
Please access the dedicated event page for more information and to register for this event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
